These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Management of severe allergic conjunctivitis with topical cyclosporin a 0.05% eyedrops. Ozcan AA; Ersoz TR; Dulger E Cornea; 2007 Oct; 26(9):1035-8. PubMed ID: 17893529 [TBL] [Abstract][Full Text] [Related]
6. Topical cyclosporin A in the management of vernal keratoconjunctivitis. Gupta V; Sahu PK Eye (Lond); 2001 Feb; 15(Pt 1):39-41. PubMed ID: 11318292 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of Vernal Keratoconjunctivitis and Associated Factors. Nebbioso M; Zicari AM; Celani C; Lollobrigida V; Grenga R; Duse M Semin Ophthalmol; 2015; 30(5-6):340-4. PubMed ID: 24571721 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of Topical Cyclosporine 0.05% the Treatment of Vernal Keratoconjunctivitis. Subedi K; Sharma B; Shrestha S Nepal J Ophthalmol; 2020 Jan; 12(23):39-47. PubMed ID: 32799238 [TBL] [Abstract][Full Text] [Related]
9. A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis. Ebihara N; Ohashi Y; Uchio E; Okamoto S; Kumagai N; Shoji J; Takamura E; Nakagawa Y; Nanba K; Fukushima A; Fujishima H J Ocul Pharmacol Ther; 2009 Aug; 25(4):365-72. PubMed ID: 19441889 [TBL] [Abstract][Full Text] [Related]
10. Tacrolimus as an Effective and Safe Therapeutic Alternative in Vernal Keratoconjunctivitis Resistant to Conventional Treatment. González-Medina M; Blasco-Valero C; Martín-Begué N; Vilà-Indurain B; Garriga-Baraut T J Investig Allergol Clin Immunol; 2018 Oct; 28(5):345-346. PubMed ID: 30350791 [No Abstract] [Full Text] [Related]
11. Clinical grading of vernal keratoconjunctivitis. Bonini S; Sacchetti M; Mantelli F; Lambiase A Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):436-41. PubMed ID: 17873585 [TBL] [Abstract][Full Text] [Related]
12. Vernal keratoconjunctivitis: Result of a novel therapy with 0.1% topical ophthalmic FK-506 ointment. Vichyanond P; Tantimongkolsuk C; Dumrongkigchaiporn P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P J Allergy Clin Immunol; 2004 Feb; 113(2):355-8. PubMed ID: 14767456 [No Abstract] [Full Text] [Related]
13. Long-term safety and efficacy of topical cyclosporine in 156 children with vernal keratoconjunctivitis. Pucci N; Caputo R; Mori F; De Libero C; Di Grande L; Massai C; Bernardini R; Novembre E Int J Immunopathol Pharmacol; 2010; 23(3):865-71. PubMed ID: 20943058 [TBL] [Abstract][Full Text] [Related]
14. Vernal keratoconjunctivitis in Thailand. Kosrirukvongs P; Vichyanond P; Wongsawad W Asian Pac J Allergy Immunol; 2003 Mar; 21(1):25-30. PubMed ID: 12931748 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis. Wan XC; Dimov V Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):543-9. PubMed ID: 24490943 [TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis. Daniell M; Constantinou M; Vu HT; Taylor HR Br J Ophthalmol; 2006 Apr; 90(4):461-4. PubMed ID: 16547328 [TBL] [Abstract][Full Text] [Related]
17. Surgical debridement plus topical cyclosporine A in the treatment of vernal shield ulcers. Caputo R; Pucci N; Mori F; De Libero C; Di Grande L; Bacci GM Int J Immunopathol Pharmacol; 2012; 25(3):775-80. PubMed ID: 23058030 [TBL] [Abstract][Full Text] [Related]
18. Treatment of severe vernal keratoconjunctivitis with 1% topical cyclosporine in an Italian cohort of 197 children. Tesse R; Spadavecchia L; Fanelli P; Rizzo G; Procoli U; Brunetti L; Cardinale F; Miniello VL; Bellizzi M; Armenio L Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):330-5. PubMed ID: 19840298 [TBL] [Abstract][Full Text] [Related]
19. Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis. Gokhale NS; Samant R; Sharma V Indian J Ophthalmol; 2012; 60(3):220-3. PubMed ID: 22569387 [TBL] [Abstract][Full Text] [Related]